Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cognitive impairment in Parkinson’s disease: a report from a multidisciplinary symposium on unmet needs and future directions to maintain cognitive health
Jennifer G. Goldman, Beth A. Vernaleo, Richard Camicioli, et al.
npj Parkinson s Disease (2018) Vol. 4, Iss. 1
Open Access | Times Cited: 147

Showing 1-25 of 147 citing articles:

Toward clinical digital phenotyping: a timely opportunity to consider purpose, quality, and safety
Kit Huckvale, Svetha Venkatesh, Helen Christensen
npj Digital Medicine (2019) Vol. 2, Iss. 1
Open Access | Times Cited: 286
Role of astroglial toll-like receptors (TLRs) in central nervous system infections, injury and neurodegenerative diseases
Lun Li, Çiğdem Acıoğlu, Robert F. Heary, et al.
Brain Behavior and Immunity (2020) Vol. 91, pp. 740-755
Open Access | Times Cited: 214
Practical recommendations for timely, accurate diagnosis of symptomatic Alzheimer’s disease (MCI and dementia) in primary care: a review and synthesis
Jerome Liss, Sheila Seleri Assunção, James J. Cummings, et al.
Journal of Internal Medicine (2021) Vol. 290, Iss. 2, pp. 310-334
Open Access | Times Cited: 172
Efficacy of virtual reality-based training programs and games on the improvement of cognitive disorders in patients: a systematic review and meta-analysis
Khadijeh Moulaei, Hamid Sharifi, Kambiz Bahaadinbeigy, et al.
BMC Psychiatry (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 34
Ethnic Variation in the Manifestation of Parkinson’s Disease: A Narrative Review
Aaron Ben-Joseph, Charles R. Marshall, Andrew J. Lees, et al.
Journal of Parkinson s Disease (2019) Vol. 10, Iss. 1, pp. 31-45
Open Access | Times Cited: 107
Cognitive Impairment and Dementia in Parkinson Disease
Jennifer G. Goldman, Erica Sieg
Clinics in Geriatric Medicine (2020) Vol. 36, Iss. 2, pp. 365-377
Closed Access | Times Cited: 71
Microbial Infections Are a Risk Factor for Neurodegenerative Diseases
Sarah K. Lotz, Britanie M. Blackhurst, Katie L. Reagin, et al.
Frontiers in Cellular Neuroscience (2021) Vol. 15
Open Access | Times Cited: 67
The default mode network and cognition in Parkinson's disease: A multimodal resting‐state network approach
Marina C. Ruppert, Andrea Greuel, Julia Freigang, et al.
Human Brain Mapping (2021) Vol. 42, Iss. 8, pp. 2623-2641
Open Access | Times Cited: 64
Management of psychiatric and cognitive complications in Parkinson’s disease
Daniel Weintraub, Dag Aarsland, Roberta Biundo, et al.
BMJ (2022), pp. e068718-e068718
Open Access | Times Cited: 45
Interplay between aging and other factors of the pathogenesis of age-related macular degeneration
Janusz Błasiak, Piotr Sobczuk, Elżbieta Pawłowska, et al.
Ageing Research Reviews (2022) Vol. 81, pp. 101735-101735
Open Access | Times Cited: 42
Cognitive heterogeneity in Parkinson’s disease: A mechanistic view
Marc Cárceles-Cordon, Dan Weintraub, Alice Chen‐Plotkin
Neuron (2023) Vol. 111, Iss. 10, pp. 1531-1546
Open Access | Times Cited: 26
Approach to Cognitive Impairment in Parkinson’s Disease
Qiang Zhang, Georgina M. Aldridge, Nandakumar S. Narayanan, et al.
Neurotherapeutics (2020) Vol. 17, Iss. 4, pp. 1495-1510
Open Access | Times Cited: 54
Anxiety: An ignored aspect of Parkinson’s disease lacking attention
Dharmendra Kumar Khatri, Mamta Choudhary, Anika Sood, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 131, pp. 110776-110776
Open Access | Times Cited: 52
Computerized cognitive training in Parkinson’s disease: A systematic review and meta-analysis
Hanna Malmberg Gavelin, Magdalena Eriksson Domellöf, Isabella Hoi Kei Leung, et al.
Ageing Research Reviews (2022) Vol. 80, pp. 101671-101671
Closed Access | Times Cited: 34
The effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on the cognitive and motor functions in rodents: A systematic review and meta-analysis
Abdolvahed Narmashiri, Mojtaba Abbaszadeh, Ali Ghazizadeh
Neuroscience & Biobehavioral Reviews (2022) Vol. 140, pp. 104792-104792
Closed Access | Times Cited: 29
Effectiveness of home-based rehabilitation using active video games on quality of life, cognitive and motor functions in people with Parkinson’s disease: a systematic review
Matthieu Gallou-Guyot, Dijana Nuic, Stéphane Mandigout, et al.
Disability and Rehabilitation (2022) Vol. 44, Iss. 26, pp. 8222-8233
Closed Access | Times Cited: 28
Mild cognitive impairment in patients with Parkinson’s disease: An updated mini-review and future outlook
Rwei‐Ling Yu, Ruey‐Meei Wu
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 28
Effects of physical exercise interventions on cognitive function in Parkinson's disease: An updated systematic review and meta-analysis of randomized controlled trials
Ryul Kim, Tae Lee Lee, Hanall Lee, et al.
Parkinsonism & Related Disorders (2023) Vol. 117, pp. 105908-105908
Open Access | Times Cited: 16
Melatonin/polydopamine nanostructures for collective neuroprotection-based Parkinson's disease therapy
Anup K. Srivastava, Subhasree Roy Choudhury, Surajit Karmakar
Biomaterials Science (2019) Vol. 8, Iss. 5, pp. 1345-1363
Closed Access | Times Cited: 44
Comparative Efficacy, Safety, and Acceptability of Pimavanserin and Other Atypical Antipsychotics for Parkinson’s Disease Psychosis: Systematic Review and Network Meta-Analysis
Ismaeel Yunusa, Nazia Rashid, Roxanna Seyedin, et al.
Journal of Geriatric Psychiatry and Neurology (2023) Vol. 36, Iss. 5, pp. 417-432
Closed Access | Times Cited: 13
Dalzanemdor (SAGE‐718), a novel, investigational N‐methyl‐D‐aspartate receptor positive allosteric modulator: Safety, tolerability, and clinical pharmacology in randomized dose‐finding studies in healthy participants and an open‐label study in participants with Huntington's disease
Aaron Koenig, Michael Lewis, Jeff Wald, et al.
Clinical and Translational Science (2024) Vol. 17, Iss. 7
Open Access | Times Cited: 4
Managing cognitive impairment in Parkinson’s disease: an update of the literature
Jennifer G. Goldman, Priya Jagota, Elie Matar
Expert Review of Neurotherapeutics (2025), pp. 1-21
Closed Access
Exercise Strategies for Parkinson Disease Management
Spencer Ingoglia, B. Sue Graves
Strength and conditioning journal (2025)
Closed Access
<p>Using The Apriori Algorithm To Classify The Care Needs Of Patients With Different Types Of Dementia</p>
Kai-Ming Jhang, Ming-Che Chang, Tzu-Ying Lo, et al.
Patient Preference and Adherence (2019) Vol. Volume 13, pp. 1899-1912
Open Access | Times Cited: 36
Impact of Coronavirus Disease 2019 Pandemic on Cognition in Parkinson's Disease
Giovanni Palermo, Luca Tommasini, Filippo Baldacci, et al.
Movement Disorders (2020) Vol. 35, Iss. 10, pp. 1717-1718
Open Access | Times Cited: 32
Page 1 - Next Page

Scroll to top